24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Pfizer
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
11:16
Israeli tech’s top 10 funding rounds of 2024: Wiz sets another record
08:58
Israel will "experience a 'baby boom' of innovation" in 2025, says RUNI Ventures
18:00
Vgames raises $142 million to fuel global gaming investments
17:14
Full list of Israeli startup M&As in 2024
More stories
Buzz
Most popular
Daily
Weekly
1
Four months after Intel shut it down, Ignite relaunches as an independent accelerator
2
Boomi acquires Israeli data management startup Rivery in $100M deal
3
Israel launches its first domestically built quantum computer
4
Chainalysis acquires Israeli blockchain security startup Hexagate in $60M deal
5
“I foresee one of the best decades in the history of the State of Israel”
More news
Pfizer
20 stories about Pfizer
CytoReason raises $80 million, including from NVIDIA and Pfizer, to scale its AI disease models
17.07.24
|
Meir Orbach
The Israeli startup provides therapeutic area leaders with molecular-level insights and valuable AI tools to make data-driven decisions, helping them improve the probability of phase 2 success and optimize their R&D portfolio.
Technion and Pfizer sign agreement to boost drug development with AI
15.01.23
|
CTech
The Technion aims to advance technological and medical developments by identifying new technologies and various digital tools with potential industrial application
CytoReason raises $20 million from Pfizer for AI drug discovery and development platform
20.09.22
|
Meir Orbach
Pfizer will also have options to license the Israeli startup’s platform and disease models, and fund supplementary project support, in a deal potentially worth up to $110 million over the next five years
Israeli study reveals South African variant may evade Pfizer vaccine
12.04.21
|
Reuters
Almost 53% of Israel's 9.3 million population has received both Pfizer doses, and has largely reopened its economy in recent weeks
Moderna CMO suggests Israel is on its radar for new vaccine production facility
25.02.21
|
Sophie Shulman
Tal Zaks says the drugmaker has already produced a booster shot to counter the South African variant, says his mom in Israel received the competition’s vaccine
Proof in the numbers: Israeli HMO reinforces Covid-19 vaccine efficacy findings by Pfizer
18.02.21
|
Reuters
Only 608 people out of a total 602,000 had tested positive for Covid-19 more than a week after receiving second dose
Survey finds majority of Israelis aren’t worried about sharing vaccine data with drug companies
04.02.21
|
CTech
While Israelis overwhelmingly disagree with sharing their medical data with state security agencies, they are willing to do so with drugmakers in exchange for Covid-19 vaccines
Israel includes teens in vaccination drive, eyeing exams
24.01.21
|
Reuters
As part of the nationwide vaccination campaign, teens will receive the new Covid-19 vaccines as well so that they may return to school
Dissecting the data-sharing deal: Should Israelis be worried about Pfizer getting private info?
19.01.21
|
Dov Greenbaum
Israel truly has an opportunity to be a light unto the nations by helping everyone else optimally distribute their vaccines in their own jurisdictions, but at what cost?
Human experimentation oversight committee wants to approve Israel-Pfizer data-sharing deal
19.01.21
|
Adrian Filut
Does research to examine Covid-19 vaccine’s effectiveness at achieving herd immunity risk citizens’ privacy?
How did an Israeli robotics company catch Elon Musk's attention and why is every criminal on the planet your next-door neighbor?
18.01.21
|
CTech
CTech Daily Roundup: Meet the Israeli company that has ballooned to a valuation of $1.4 billion despite nano-sized sales
Responding to calls for transparency, Israel publishes contract of data-sharing vaccine deal with Pfizer
17.01.21
|
CTech
Redacted document appears to confirm health ministry statements that only publicly available information will be shared
“We’re lucky that the mutations only affected the rate of infection, they could have created a far more violent virus”
16.01.21
|
Diana Bahur-Nir
Prof. Ron Diskin, an expert on deadly viruses, isn’t worried that the new Covid-19 vaccine will lose its effectiveness but is concerned about millennials’ cavalier attitude toward the disease
Israel’s one of a kind healthcare system is a rare opportunity for Pfizer
12.01.21
|
Elihay Vidal
The 25 years of accumulating digital medical data can help Israel optimize its Covid-19 vaccination campaign and benefit all of humankind, says Orli Tori, a partner at Triventures ARC
Israel can use medical data to defeat the virus without violating people’s privacy
11.01.21
|
James Spiro
In exchanging digitized healthcare data for vaccination shots, Prime Minister Benjamin Netanyahu assured citizens their personal data is safe. Dr. Nimrod Kozlovski, Head of Tech and Regulation at HFN, shares his thoughts on the deal
How is technology and data helping Israel become the first country to vanquish Covid-19?
10.01.21
|
Elihay Vidal
Israel is well on its way to vaccinating its entire adult population and in exchange for delivering millions of vaccine doses, the government has pledged to give drugmaker Pfizer medical data on the millions of vaccine recipients from the health system’s vast databases
These are the key ingredients of Israel's rapid Covid-19 vaccine rollout recipe
06.01.21
|
Reuters
Two weeks into its vaccination drive, Israel has reached nearly 15% of the population by paying premium prices, relying on universal healthcare, and minimizing waste
Pfizer, AstraZeneca, Merck, and Teva win tender for new Israeli Innovation Lab
27.12.20
|
James Spiro
The lab, which is set to research digital health and computational biology, has a government budget of $9.9 million
Will the quickly developed vaccines deliver Covid-19 a knockout blow?
13.12.20
|
Sophie Shulman
An urgent global crisis, near-limitless funds, and a scientific development ripe for use combined to produce rapid results, but will today’s vaccines eradicate the pandemic?
Survey: One-third of Israelis would prefer to take homegrown Covid-19 vaccine
10.12.20
|
James Spiro
The results come a day after America’s Pfizer/BioNTech vaccine touches down for distribution
More Articles
Please ensure Javascript is enabled for purposes of
website accessibility